Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
59%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
THNR
17
HOLDINGS
74%
ALSO IN OZEM
OZEM
22
HOLDINGS
67%
ALSO IN THNR
SECTOR DRIFT (THNR minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 17.0% | 12.3% |
 |
NOVO-NORDISK A/S-SPONS ADR | 9.6% | 13.4% | 9.6% |
|
PFIZER INC | 5.3% | 7.1% | 5.3% |
 |
INNOVENT BIOLOGICS, INC. | 4.7% | 4.8% | 4.7% |
|
AMGEN INC | 7.8% | 4.0% | 4.0% |
THNR Overweight Relative to OZEM
|
MERCK & CO. INC. | 6.0% |
|
ABBVIE INC | 5.0% |
 |
SHIONOGI & CO LTD | 4.9% |
|
AMGEN INC | 3.8% |
|
CHUGAI PHARMACEUTICAL CO LTD | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.4% |
|
HIMS & HERS HEALTH, INC. CLASS A | 2.5% |
 |
ASTRAZENECA PLC | 1.8% |
|
SCHOLAR ROCK HOLDING CORP. | 1.6% |
THNR Underweight Relative to OZEM
|
ELI LILLY & CO | -4.7% |
 |
ASCLETIS PHARMA, INC. | -4.1% |
|
VIKING THERAPEUTICS, INC. | -3.8% |
|
NOVO-NORDISK A/S-SPONS ADR | -3.8% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.1% |
 |
THE UNITED LABORATORIES INTE | -2.6% |
 |
HANMI PHARM CO LTD | -2.6% |
|
GILEAD SCIENCES INC | -2.0% |
|
ZEALAND PHARMA A/S | -1.9% |
|
PFIZER INC | -1.8% |